MedPath

Strengthening Inspiratory and Oropharyngeal Muscles in Moderate Obstructive Sleep Apnea Hypopnea Syndrome

Not Applicable
Recruiting
Conditions
Obstructive Sleep Apnea
Interventions
Other: Inspiratory and Oropharyngeal Muscle Strengthening
Registration Number
NCT06471751
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

The Obstructive Sleep Apnea hypopnea Syndrome (OSAS), whose prevalence is 4% of the French population, can lead to serious health consequences (risk of road accidents, onset of cardiovascular disease, etc.). OSAS corresponds to a certain number of interruptions (apneas) or reductions (hypopneas) of ventilation during sleep. The weakening of the tone of the inspiratory and oropharyngeal muscles is one of the main causes of upper airways obstruction during the inspiratory phase.

Detailed Description

For patients with moderate OSAS, with few or no symptoms, without associated cardiovascular comorbidities, there is no recommended treatment. Rehabilitate the inspiratory and oropharyngeal muscles through muscle strengthening seems to be an alternative to this problem. Therefore, this study proposes a complete rehabilitation care evaluating the effectiveness of the strengthening of inspiratory and oropharyngeal muscles in subject with moderate OSAS.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Moderate SAHOS (15 ≤ AHI ≤30);
  • Body Mass Index (BMI) < 35 ;
  • Patient affiliated or entitled to a social security scheme;
  • Patient having signed a consent to participate in the study.
Exclusion Criteria
  • Excessive daytime sleepiness: Epworth sleepiness score > 10 ;
  • Professional driving and history of accidents related to sleepiness;
  • Severe obstructive or restrictive ventilatory disorders of neuromuscular origin authenticated by respiratory function tests;
  • Patients undergoing treatment for OSAS or requiring immediate initiation of continuous positive airway pressure (CPAP) or a mandibular advancement orthosis;
  • Patients who have stopped CPAP or orthosis treatment in less than one month;
  • Patients undergoing cardiorespiratory exercise rehabilitation or starting regular physical training;
  • Uncompensated heart failure, thoracic sternotomy surgery < 4 months;
  • Marked osteoporosis with history of rib fractures;
  • History of spontaneous pneumothorax;
  • Severe asthma;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Strengthening muscles groupInspiratory and Oropharyngeal Muscle StrengtheningHome training to strengthen Inspiratory and Oropharyngeal muscles
Primary Outcome Measures
NameTimeMethod
Apnea-Hypopnea Index (AHI)At 3 months

AHI is measured by polygraphy or polysomnography. It is not a score

Secondary Outcome Measures
NameTimeMethod
Maximum inspiratory pressure measurement (cmH2O)At 3 and 9 Months

Measured by POWERbreathe® K5

Neck circumference (cm)At 3 months

The neck circumference is measured by Magnetic Resonance Imagery (RMI)

Epworth sleepiness scoreAt 3 and 9 Months

Sleep quality assessment using the Epworth sleepiness score. From 0 to 24. If score up to 10 then the patient has signs of excessive daytime sleepiness

Pittsburgh Sleep quality indexAt 3 and 9 Months

Sleep quality assessment using the Pittsburgh Sleep quality index. From 0 to 21. Score 0 = very good sleep quality. Score 21 = very poor sleep quality

Quality of life scale : Short Form 12 (SF12)At 3 and 9 Months

Quality of life assessment using the scale SF12 From 43 to 118 the higher the score, the better the quality of life

PICOT fatigue scaleAt 3 and 9 Months

Fatigue assessment using the PICOT scale From 0 to 32 If score up to 22 then the patient has signs of excessive sleepiness

AHI (Apnea-Hypopnea Index)At 9 months

AHI is measured by polygraphy or polysomnography It is not a score

Trial Locations

Locations (2)

CHU de Grenoble

🇫🇷

Grenoble, France

Centre Hospitalier Universitaire

🇫🇷

Saint-Étienne, France

© Copyright 2025. All Rights Reserved by MedPath